MEL-P, a GM-CSF-producing human melanoma cell line

Melanoma Research

Volumn 6, Issue 3, 1996, Pages 203-213

  Ciotti, P ^a   Imro, A ^b   Scudeletti, M ^b   Rainero, M L ^c   Defferrari, R ^a   Ghiorzo, P ^c   Indiveri, F ^b   Bianchi Scarra G ^a  

^a Institute of Biology and Genetics   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

Author keywords

GM CSF; HLA I; ICAM 1; Melanoma cell line

Indexed keywords

ALPHA INTERFERON; ANTISENSE OLIGODEOXYNUCLEOTIDE; BASIC FIBROBLAST GROWTH FACTOR; COMPLEMENTARY DNA; CYTOKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HLA ANTIGEN CLASS 1; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; INTERLEUKIN 8; MESSENGER RNA; MONOCLONAL ANTIBODY;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER IMMUNOLOGY; CANCER INHIBITION; CASE REPORT; CYTOGENETICS; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; MALE; MELANOMA; MELANOMA CELL; METASTASIS; PRIORITY JOURNAL;

ADULT; CELL DIVISION; CELL LINE; CHROMOSOME ABERRATIONS; CULTURE TECHNIQUES; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOPHENOTYPING; KARYOTYPING; KINETICS; MALE; MELANOMA; OLIGONUCLEOTIDES, ANTISENSE; POLYMERASE CHAIN REACTION; RECEPTORS, GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; RNA, MESSENGER; SKIN NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0029957110     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008390-199606000-00003     Document Type: Article

References (43)

1. Rodeck U. Growth factor independence and growth regulatory pathways in human melanoma development. Cancer Metastasis Rev 1993; 12: 219-226.
2. Albino AP, Davis BM, Nanus DM. Induction of growth factor RNA expression in human malignant melanoma: markers of transformation. Cancer Res 1991; 51: 4815-4820.
3. Mattei S, Colombo MP, Melani C, et al. Expression of cytokine/growth factors and their receptors in human melanoma and melanocytes. Int J Cancer 1994; 56: 853-857.
4. Fearon ER, Pardoll DM, Itaya T, et al. Interleukin-2 production by tumour cells bypasses T helper function in the generation of an an antitumour response. Cell 1990; 60: 397-403.
5. Tepper RI, Pattengale PK, Leder P. Murine interleukin-4 displays potent anti-tumour activity in vivo. Cell 1989; 57: 503-512.
6. Miller AR, McBride WH, Dubinett SM, et al. Transduction of human melanoma cell lines with the human interleukin-7 gene using retroviral-mediated gene transfer: comparison of immunologic properties with interleukin-2. Blood 1993; 82: 3686-3694.
7. Gansbacher B, Bannerji R, Daniels B, et al. Retroviral vector-mediated γ-interferon gene transfer into tumour cells generates potent and long lasting antitumour immunity. Cancer Res 1990; 50: 7820-7825.
8. Mochizuki DY, Eisenman JR, Conlon PJ, et al. Interleukin-1 regulates haematopoietic activity, a role previously ascribed to haemopoietin 1. Proc Natl Acad Sci USA 1987; 84: 5267-5271.
9. Dedhar S, Gaboury L, Galloway P, et al. Human granulocyte-macrophage colony-stimulating factor is a growth factor active on a variety of cell types of nonhaemopoietic origin. Proc Natl Acad Sci USA 1988; 85: 9253-9257.
10. Berdel WB, Danhauser-Riedl S, Steinhauser G, et al. Various human haematopoietic growth factors - interleukin-3, GM-CSF, G-CSF - stimulate clonal growth of nonhaemopoietic tumour cells. Blood 1989; 73: 80-83.
11. Colombo MP, Maccalli C, Mattei S, et al. Expression of cytokine genes, including IL-6, in human malignant cell lines. Melanoma Res 1992; 2: 181-189.
12. Ciotti P, Rainero ML, Nicolò G, et al. Cytokine expression in human primary and metastatic melanoma cells: analysis in fresh bioptic specimens. Melanoma Res 1995; 5: 41-47.
13. Dranoff G, Jaffee E, Lazenby AE, et al. Vaccination with irradiated tumour cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumour immunity. Proc Natl Acad Sci USA 1993; 90: 3539-3543.
14. Vose BM, Moore M. Supressor cell activity of lymphocytes infiltrating human lung and breast tumours. Int J Cancer 1979; 24: 579-585.
15. Parham P, Barnstable CJ, Bodmer WF. Use of a monoclonal antibody (W6/32) in structural studies of HLA-A, B, C antigens. J Immunol 1979; 123: 342-345.
16. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-159.
17. Wong GG, Witeck JS, Temple PA, et al. Human GM-CSF: molecular cloning of the complementary DNA and purification of the natural and recombinant proteins. Science 1985; 228: 810-815.
18. Bradley RT, Metcalf D. The growth of bone marrow cells in vitro. Aust J Exp Biol Med Sci 1966; 44: 287-300.
19. Segal GM, Smith TD, Heinrich MC, et al. Specific repression of granulocyte-macrophage and granulocyte-colony-stimulating factor gene expression in interleukin-1-stimulated endothelial cells with antisense oligodeoxynucleotides. Blood 1992; 80: 609-616.
20. Mitelman F. Catalogue of Chromosome Aberrations in Cancer, 3rd ed. New York: Alan Liss, 1988.
21. Trent JM, Leong SP, Meyskens FL, et al. Chromosome alterations in human malignant melanoma. In: Conti C, Slaga TJ, Klein-Szanto APL, eds. Skin Tumours. Experimental and Clinical Aspects. New York: Raven Press, 1989: 165-186.
22. Loreau N, Boiziau C, Verspieren P, et al. Blockade of AMV reverse transcriptase by antisense oligonucleotides. FEBS Lett 1990; 274: 53-55.
23. Meanread A, Herlyn M. Tumour progression, biology, and host response in melanoma. Curr Opinion Oncol 1992; 14: 351-356.
24. Rynger TM, Klein CE, Becker JC, et al. The role of genetic instability, adhesion, cell motility, and immune escape mechanisms in melanoma progression. Curr Opinion Oncol 1994; 6: 188-196.
25. Baldwin GC, Golde DW, Widhoph GF, et al. Identification and characterization of a low-affinity granulocyte-macrophage colony-stimulating factor receptor on primary and cultured human melanoma cells. Blood 1991; 78: 609-615.
26. Sabatini M, Chavez J, Mundy GR, et al. Stimulation of tumour necrosis factor release from monocytic cells by the A375 human melanoma via granulocyte-macrophage colony-stimulating factor. Cancer Res 1990; 50: 2673-2678.
27. Steinman RM. The dendritic cell system and its role in immunogenicity. Ann Rev Immunol 1991; 9: 271-296.
28. Roberts PJ, Khwaja A, Lie AK, et al. Differentiation-linked changes in tyrosine phosphorylation, functional activity, and gene expression downstream from the granulocyte-macrophage colony-stimulating factor receptor. Blood 1994; 84: 1064-1073.
29. Sporn MB, Roberts AB. Autocrine growth factors and cancer. Nature 1985; 303: 745-747.
30. Aaronson SA. Growth factors and cancer. Science 1991; 254: 1146-1153.
31. Gordon MY. Haemapoietic growth factors and receptors: bound and free. Cancer Cells A Mon Rev 1991; 3: 127-133.
32. Miyamjima A, Kitamura T, Harada N, et al. Cytokine receptors and signal transduction. Ann Rev Immunol 1992; 10: 295-331.
33. Lu C, Kerbel RS. Interleukin-6: transition from paracrine growth inhibitor to intracellular autocrine stimulator during human melanoma progression. J Cell Biol 1992; 120: 1281-1288.
34. Schadendorf D, Moller A, Algermissen BE, et al. IL-8 produced by human malignant melanoma cells in vitro is an essential autocrine growth factor. J Immunol 1993; 51: 2667-2675.
35. Becker D, Meier CB, Herlyn M. Proliferation of human malignant melanomas is inhibited by antisense oligodeoxynucleotides targeted against basic fibroblast growth factor. EMBO J 1989; 8: 3685-3691.
36. Richmond A, Balentein E, Thomas HG, et al. Molecular characterization and chromosome mapping of melanoma growth stimulatory activity, a growth factor structurally related to β-thromboglobulin. EMBO J 1988; 7: 2025-2033.
37. Hart IR, Saini A. Biology of tumour metastasis. Lancet 1992; 339: 1453-1457.
38. Johnson JP, Stade BG, Rothbacher U, et al. Melanoma antigens and their association with malignant transformation and tumour progression. Eur J Immunol 1981; 11: 825-830.
39. Kageshita T, Kuriya N, Ono T, et al. Association of high molecular weight melanoma-associated antigen expression in primary acral lentiginous melanoma lesions with poor prognosis. Cancer Res 1993; 53: 2830-2833.
40. Natali P, Nicotra MR, Cavalieri RE, et al. Differential expression of intercellular adhesion molecule 1 in primary and metastatic melanoma lesions. Cancer Res 1990; 50: 1271-1278.
41. Kohn EC, Hollister GH, Dipersio JD, et al. Granulocyte-macrophage colony-stimulating factor induces human melanoma-cell migration. Int J Cancer 1993; 53: 968-972.
42. Singh RK, Gutman M, Radinsky R. Heterogeneity of cytokine and growth factor gene expression in human melanoma cells with different metastatic potentials. J Interferon Cytokine Res 1995; 15: 81-87.
43. Matsuda M, Salazar F, Petersson M, et al. Interleukin-10 pretreatment protects target cells from tumour- and allospecific cytotoxic T cells and downregulates HLA class I expression. J Exp Med 1994; 180: 2371-2376.